CRYO CELL INTERNATIONAL INC (CCEL)
2025-05-31 | 2024-08-31 | |||
|---|---|---|---|---|
| Revenue | 7,928,843 | 8,066,715 | ||
| Change in fair value of contingent consideration | - | 12,702 | ||
| Selling, general and administrative expenses | 4,257,857 | 4,149,785 | ||
| Research, development and related engineering | 131,711 | 193,933 | ||
| Impairment of investment-Tianhe Stem Cell Biotechnologies Inc | - | - | ||
| Depreciation and amortization | 190,102 | 194,559 | ||
| Cost of sales | 1,856,539 | 2,125,846 | ||
| Total costs and expenses | 6,436,209 | 6,676,825 | ||
| Operating income | 1,492,634 | 1,389,890 | ||
| Other income | 12,927 | 981 | ||
| (losses) gains on marketable securities | -379,332 | 522,458 | ||
| Interest expense | 551,126 | 533,464 | ||
| Gain on interest rate swap | - | - | ||
| Total other income (expense) | -917,531 | -10,025 | ||
| Income before income tax expense | 575,103 | 1,379,865 | ||
| Income tax expense | 219,318 | 328,186 | ||
| Net income | 355,785 | 1,051,679 | ||
| Earnings per share, basic, total | 0.04 | 0.13 | ||
| Earnings per share, diluted, total | 0.04 | 0.13 | ||
| Weighted average number of shares outstanding, basic, total | 8,080,161 | 8,061,946 | ||
| Weighted-average shares-diluted | 8,125,720 | 8,173,535 | ||